{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:38:56Z","timestamp":1782977936003,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["RD\/17\/0047"],"award-info":[{"award-number":["RD\/17\/0047"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijpddr.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T23:29:14Z","timestamp":1686180554000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Stepwise in vitro screening of MMV pathogen box compounds against Plasmodium falciparum to identify potent antimalarial candidates"],"prefix":"10.1016","volume":"22","author":[{"given":"Haddijatou","family":"Mbye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Bojang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatou Kene","family":"Jaiteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7029-5305","authenticated-orcid":false,"given":"Aminata","family":"Jawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekai","family":"Njie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-3601","authenticated-orcid":false,"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijpddr.2023.05.005_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00759-17","article-title":"Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in the Gambia","volume":"61","author":"Amambua-Ngwa","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.ijpddr.2023.05.005_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijpddr.2023.05.005_bib3","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1021\/acs.jmedchem.6b00723","article-title":"Discovery of a quinoline-4-carboxamide derivative with a novel mechanism of action, multistage antimalarial activity, and potent in vivo efficacy","volume":"59","author":"Baragana","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijpddr.2023.05.005_bib4","first-page":"917","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nature Medicine 2017 23:8"},{"key":"10.1016\/j.ijpddr.2023.05.005_bib5","series-title":"Drug Resistance in Malaria","author":"Bloland","year":"2001"},{"issue":"1779","key":"10.1016\/j.ijpddr.2023.05.005_bib6","article-title":"Applicability of drug response metrics for cancer studies using biomaterials","volume":"374","author":"Brooks","year":"2019","journal-title":"Philosoph. Trans. Royal Soc. B"},{"issue":"11","key":"10.1016\/j.ijpddr.2023.05.005_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01053-18","article-title":"Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. Berghei Identifies Transmission-Blocking Compounds","volume":"62","author":"Calit","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2023.05.005_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s12885-017-3689-3","article-title":"GRcalculator: an online tool for calculating and mining dose-response data","volume":"17","author":"Clark","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ijpddr.2023.05.005_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpara.2020.01.002","article-title":"Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds","volume":"50","author":"Dans","year":"2020","journal-title":"Int. J. Parasitol."},{"issue":"9","key":"10.1016\/j.ijpddr.2023.05.005_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.005_bib12","author":"Dunyo"},{"key":"10.1016\/j.ijpddr.2023.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04333","article-title":"An open investigation of the reproducibility of cancer biology research","volume":"3","author":"Errington","year":"2014","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.ijpddr.2023.05.005_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.ijpddr.2023.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00720-20","article-title":"Tolerance of Gambian Plasmodium falciparum to dihydroartemisinin and lumefantrine detected by ex vivo parasite survival rate assay","volume":"65","author":"Mbye","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ijpddr.2023.05.005_bib18","article-title":"Artemisinin-based combination treatment of falciparum malaria - defining and defeating the intolerable burden of malaria III: progress and perspectives","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"387","key":"10.1016\/j.ijpddr.2023.05.005_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijpddr.2023.05.005_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01802-19","article-title":"Whole-cell phenotypic screening of medicines for malaria venture pathogen box identifies specific inhibitors of Plasmodium falciparum late-stage development and egress","volume":"64","author":"Patra","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ijpddr.2023.05.005_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharmaceut. Stat."},{"issue":"8","key":"10.1016\/j.ijpddr.2023.05.005_bib24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","article-title":"High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine","volume":"225","author":"Straimer","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.ijpddr.2023.05.005_bib25","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"Thu","year":"2017","journal-title":"FEBS J."},{"issue":"4254","key":"10.1016\/j.ijpddr.2023.05.005_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ijpddr.2023.05.005_bib28","first-page":"1602","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med. 2020 26:10"},{"issue":"9","key":"10.1016\/j.ijpddr.2023.05.005_bib29","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2666-5247(22)00155-0","article-title":"Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study","volume":"3","author":"Watson","year":"2022","journal-title":"The Lancet Microbe"},{"issue":"6","key":"10.1016\/j.ijpddr.2023.05.005_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2023.05.005_bib33","series-title":"Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010-2019)","year":"2020"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320723000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320723000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:44Z","timestamp":1761922364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320723000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":25,"alternative-id":["S2211320723000209"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2023.05.005","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stepwise in vitro screening of MMV pathogen box compounds against Plasmodium falciparum to identify potent antimalarial candidates","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}